GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Dror Ortho-Design Inc (OTCPK:DROR) » Definitions » Risk Assessment

DROR (Dror Ortho-Design) Risk Assessment


View and export this data going back to 2004. Start your Free Trial

What is Dror Ortho-Design Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Dror Ortho-Design is: No Data: Cannot be evaluated.

Competitive Comparison of Dror Ortho-Design's Risk Assessment

For the Personal Services subindustry, Dror Ortho-Design's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dror Ortho-Design's Risk Assessment Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Dror Ortho-Design's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Dror Ortho-Design's Risk Assessment falls into.


Dror Ortho-Design  (OTCPK:DROR) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Dror Ortho-Design Risk Assessment Related Terms

Thank you for viewing the detailed overview of Dror Ortho-Design's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Dror Ortho-Design Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Dror Ortho-Design Inc (OTCPK:DROR) » Definitions » Risk Assessment
Comparable Companies
EJH IVP TRNR CLIK EVTK ROL SCI BFAM HRB FTDR HKSE:01448 LSE:XPS LSE:CVSG ROCO:5530 XTER:CWC OHEL:MUSTI CSV ASX:PFP LSE:MER TSE:2305
Traded in Other Exchanges
N/A
Address
Shatner Street 3, Suite 400W, Rockville Center, Jerusalem, ISR
Website
https://www.novint.com
Dror Ortho-Design Inc is focused on engaging the customer throughout their smile correction journey and beyond. Its solution provides an, proprietary end-to-end platform that spans all stages of customer engagement, from initial acquisition to treatment and ongoing maintenance all with minimal need for office visits and lifestyle inconvenience.
Executives
Eliyahu Haddad director, officer: Chief Executive Officer SHATNER STREET 3, JERUSALEM L3 NA
Chaim Ravad director SHATNER STREET 3, JERUSALEM L3 NA
Yehuda Englander director SHATNER STREET 3, JERUSALEM L3 NA
Moshe Shvets director, officer: Chief Technology Officer SHATNER STREET 3, JERUSALEM L3 NA
Chaim Hurvitz director C/O GALMED PHARMACEUTICALS LTD., 8 SHAUL, HAMELECH BLVD, AMOT HAMISHPAT BLDG., TEL AVIV L3 64733
Orin Hirschman director, officer: Chief Executive Officer 101 EAST 52ND ST, NEW YORK NY 10022
Ryan Christoff director 480 JOHNSON ROAD SUITE 303, WASHINGTON PA 15301
Congregation Ahavas Tzdokah Vchesed Inc. 10 percent owner, other: See Explanation of Responses 1347 42ND STREET, BROOKLYN NY 11219
Ellis International L.p. other: See Explanation of Responses 100 MERRICK ROAD, SUITE 400W, ROCKVILLE CENTRE NY 11570
Brian W Long director 1010 OHIO RIVER BLVD., PITTSBURGH PA 15202
Shannon Lee Vissman director, 10 percent owner 1241 TURNBERRY DRIVE, UPPER ST. CLAIR PA 15241
Jan K Richardson director 1821 HILLANDALE RD., SUITE 307, DURHAM NC 27705
Aigh Investment Partners, Llc 10 percent owner 6006 BERKELEY AVENUE, BALTIMORE MD 21209
V Gerald Grafe director 901 RIO GRANDE BOULEVARD NW, BUILDING H, SUITE 262, ALBUQUERQUE NM 87104
Walter A Aviles 10 percent owner, officer: Chief Technical Officer 9620 SAN MATEO BOULEVARD NE, ALBUQUERQUE NM 87113